FC
GDRX icon

Fairscale Capital’s GoodRx Holdings GDRX Stock Holding History

Fairscale Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08K Hold
1,060
– – ﹤0.01% 386
2025
Q4 		$2.87K Buy
+1,060
New +$3.48K ﹤0.01% 359

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Fairscale Capital's GDRX Position: Q1 2026 in Review

Fairscale Capital held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 1,060 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Fairscale Capital first reported a position in GDRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.87K in Q4 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Fairscale Capital held 1,060 shares of GoodRx Holdings worth $2.08K as of Q1 2026.
  • Fairscale Capital left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Fairscale Capital's portfolio in Q1 2026, its #386 holding.
  • Fairscale Capital first reported a position in GoodRx Holdings in Q4 2025 and has held it in 2 quarters since.
  • Fairscale Capital's GoodRx Holdings position peaked at $2.87K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.